Close Menu

A post by Vivian Cheng at Science Progress chronicles a recent accusation of data-falsification in a study on a bone-growth treatment. Timothy Kuklo, a former Army orthopedic surgeon now at Washington University in St. Louis authored an article in the British Journal of Bone and Joint Surgery that said Medtronic's Infuse was better at treating severe leg injuries suffered by soldiers than traditional therapies.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

New analyses indicate the P.1 variant found in Brazil may be able to infect people who have already had COVID-19, the New York Times reports.

According to CNBC, Novavax's CEO says its vaccine could be authorized in the US as early as May.

The US National Institutes of Health has a new initiative to address structural racism in biomedical research.

In PNAS this week: GWAS of TLV-1-associated myelopathy/tropical spastic paraparesis, analysis of twins with hypertrophic cardiomyopathy, and more.